Astrana Health, Inc. (ASTH) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 8 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ASTH is $32.75, representing a +12.7% upside from the current price of $29.07. Price targets range from a low of $26.00 to a high of $40.00.
